List of Excipients in API rasagiline mesylate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing rasagiline mesylate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | AZILECT | rasagiline mesylate | 43353-015 | MANNITOL | |
| Aphena Pharma Solutions - Tennessee LLC | AZILECT | rasagiline mesylate | 43353-015 | SILICON DIOXIDE | |
| Aphena Pharma Solutions - Tennessee LLC | AZILECT | rasagiline mesylate | 43353-015 | STARCH, CORN | |
| Aphena Pharma Solutions - Tennessee LLC | AZILECT | rasagiline mesylate | 43353-015 | STEARIC ACID | |
| Aphena Pharma Solutions - Tennessee LLC | AZILECT | rasagiline mesylate | 43353-015 | TALC | |
| Physicians Total Care Inc | AZILECT | rasagiline mesylate | 54868-6206 | MANNITOL | |
| Physicians Total Care Inc | AZILECT | rasagiline mesylate | 54868-6206 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing rasagiline mesylate
Detailed excipient profiles for rasagiline mesylate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
rasagiline mesylate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Avet Pharmaceuticals Inc | rasagiline mesylate | 23155-746 |
| >Company | >Ingredient | >NDC |
rasagiline mesylate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
rasagiline mesylate drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | rasagiline mesylate | 0378-1270 |
| Avet Pharmaceuticals Inc | rasagiline mesylate | 23155-746 |
| >Company | >Ingredient | >NDC |
rasagiline mesylate drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | rasagiline mesylate | 43353-015 |
| Physicians Total Care Inc | rasagiline mesylate | 54868-6206 |
| Teva Neuroscience Inc | rasagiline mesylate | 68546-142 |
| Teva Neuroscience Inc | rasagiline mesylate | 68546-229 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
rasagiline mesylate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | rasagiline mesylate | 0378-1270 |
| >Company | >Ingredient | >NDC |
rasagiline mesylate drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: MANNITOL
rasagiline mesylate drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | rasagiline mesylate | 43353-015 |
| Physicians Total Care Inc | rasagiline mesylate | 54868-6206 |
| Teva Neuroscience Inc | rasagiline mesylate | 68546-142 |
| Teva Neuroscience Inc | rasagiline mesylate | 68546-229 |
| >Company | >Ingredient | >NDC |
rasagiline mesylate drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | rasagiline mesylate | 0378-1270 |
| Avet Pharmaceuticals Inc | rasagiline mesylate | 23155-746 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
rasagiline mesylate drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | rasagiline mesylate | 0378-1270 |
| >Company | >Ingredient | >NDC |
rasagiline mesylate drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: SILICON DIOXIDE
rasagiline mesylate drug variants containing SILICON DIOXIDE
rasagiline mesylate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
rasagiline mesylate drug variants containing STARCH, CORN
rasagiline mesylate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rasagiline mesylate | 54868-6206 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
rasagiline mesylate drug variants containing STEARIC ACID
rasagiline mesylate drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
rasagiline mesylate drug variants containing TALC
rasagiline mesylate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | rasagiline mesylate | 0378-1270 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
